Molecular markers to complement sentinel node status in predicting survival in patients with high risk locally invasive melanoma.
Green, Adèle C
AffiliationThe University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, QLD, Australia
MetadataShow full item record
AbstractSentinel lymph node status is a major prognostic marker in locally invasive cutaneous melanoma. However this procedure is not always feasible, requires advanced logistics, and carries rare but significant morbidity. Previous studies have linked markers of tumour biology to patient survival. In this study we aimed to combine the predictive value of established biomarkers in addition to clinical parameters as indicators of survival in addition to or instead of sentinel node biopsy in a cohort of high risk melanoma patients. Patients with locally invasive melanomas undergoing sentinel lymph node biopsy were ascertained and prospectively followed. Information on mortality was validated through the National Death Index. Immunohistochemistry was used to analyse proteins previously reported to be associated with melanoma survival, namely Ki67, p16, and CD163. Evaluation and multivariate analyses according to REMARK criteria were used to generate models to predict disease-free and melanoma-specific survival. 189 patients with available archival material of their primary tumour were analysed. Our study sample was representative of the entire cohort (N=559). Average Breslow thickness was 2.5 mm. 32 (17%) patients in the study sample died from melanoma during the follow-up period. A prognostic score was developed and was strongly predictive of survival, independent of sentinel node status. The score allowed classification of risk of melanoma death in sentinel node negative patients. Combining clinicopathological factors and established biomarkers allows prediction of outcome in locally invasive melanoma and might be implemented in addition to or in cases when sentinel node biopsy cannot be performed. This article is protected by copyright. All rights reserved.
CitationMolecular markers to complement sentinel node status in predicting survival in patients with high risk locally invasive melanoma. 2016: Int J Cancer
JournalInternational Journal of Cancer
- Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
- Authors: Speijers MJ, Bastiaannet E, Sloot S, Suurmeijer AJ, Hoekstra HJ
- Issue date: 2015 Sep
- Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
- Authors: Wagner JD, Ranieri J, Evdokimow DZ, Logan T, Chuang TY, Johnson CS, Jung SH, Wenck S, Coleman JJ 3rd
- Issue date: 2003 Aug
- [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
- Authors: Keijzer R, Bril H, van der Loo EM, de Graaf PW
- Issue date: 2004 May 1
- Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.
- Authors: Ulmer A, Dietz K, Hodak I, Polzer B, Scheitler S, Yildiz M, Czyz Z, Lehnert P, Fehm T, Hafner C, Schanz S, Röcken M, Garbe C, Breuninger H, Fierlbeck G, Klein CA
- Issue date: 2014 Feb
- Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
- Authors: Naffouje S, Naffouje R, Bhagwandin S, Salti GI
- Issue date: 2015 Dec